Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(17%)
Results Posted
100%(4 trials)

Phase Distribution

Ph phase_4
1
17%
Ph phase_1
2
33%
Ph phase_3
1
17%
Ph phase_2
2
33%

Phase Distribution

2

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(4)
Other(1)

Detailed Status

Completed4
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (33.3%)
Phase 22 (33.3%)
Phase 31 (16.7%)
Phase 41 (16.7%)

Trials by Status

unknown117%
recruiting117%
completed467%

Recent Activity

1 active trials
Showing 5 of 6
recruitingphase_3

Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"

NCT04204252
completedphase_4

Anti-inflammatory Therapy to Improve Outcomes After TPIAT

NCT02713997
completedphase_2

Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant

NCT02464878
completedphase_2

A Proof of Concept Pilot Trial of Alpha-1-Antitrypsin for Pre-Emption Of Steroid-Refractory Acute GVHD

NCT03459040
completedphase_1

Alpha-1 Anti-Trypsin (AAT) Treatment in Acute Myocardial Infarction

NCT01936896
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT04204252Phase 3

Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"

Recruiting
NCT02713997Phase 4

Anti-inflammatory Therapy to Improve Outcomes After TPIAT

Completed
NCT02464878Phase 2

Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant

Completed
NCT03459040Phase 2

A Proof of Concept Pilot Trial of Alpha-1-Antitrypsin for Pre-Emption Of Steroid-Refractory Acute GVHD

Completed
NCT01936896Phase 1

Alpha-1 Anti-Trypsin (AAT) Treatment in Acute Myocardial Infarction

Completed
NCT02191839Phase 1

Single Dose Administration of Alpha-1 Anti-Trypsin for the Amelioration of Organ Injury in Patients Undergoing Cardiac Surgery

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6